http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
IMPACT Silver Intersects 1,333 g/t Silver over 5.72m on Carlos Pacheco Vein Extension at Noche Buena Mine
-
SoftServe Cuts AI Agent Deployment from Months to Four Weeks
-
Dr. Calvin Choi, Founder of AMTD IDEA, Successfully Re-Appointed as the President of the Hong Kong Island Federation
-
Schneider Electric becomes first company with NEMA Make it American certs
-
Schneider Electric U.S. Manufacturing Facilities are now NEMA Make it American Certified
-
LIG Assets, Inc. Executes Restructuring and Conversion Agreement and Finalizes Acquisition of 1,132 Acres at Brooks Quarry in Marianna, Florida Though Wholly-Owned Subsidiary Gold Run, Inc. for $151.5
-
LIG Assets, Inc. Executes Restructuring and Conversion Agreement and Finalizes Acquisition of 1,132 Acres at Brooks Quarry in Marianna, Florida Though Wholly-Owned Subsidiary Gold Run, Inc. for $151.5
-
Blackbaud Helps Nonprofits Achieve Smarter Financial Operations with New Intelligent Advisor
-
Hyundai Launches 2026 Kona Campaign "Look At You Now" Featuring Regina Hall
-
CETY partners with Sagacity to reduce ORC component manufacturing costs
-
Join Exyn Technologies' Exclusive Live Investor Webinar and Q&A Session on June 30
-
ASUS ProArt Brings Creative Workflows to New Heights with Red Bull Athletes
-
Rubrik’s “To Catch a Thief” by Nicole Perlroth Wins a Tribeca X Award for Best Audio/Podcast
-
CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency
-
AmeriLife Earns 2026 Great Place to Work Certification(TM) for Second Consecutive Year
-
Entera reports comparable results for single-tablet EB613 versus injection
-
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
-
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
-
Slate Grocery REIT Announces Distribution for the Month of June 2026
-
Beazer Homes plans $400 million bond offering to refinance 2027 notes
-
Beazer Homes Announces Proposed Offering of $400 Million of Senior Unsecured Notes Due 2032
-
Lightbridge to Participate in Upcoming Investor and Nuclear Industry Events
-
Context Therapeutics reports interim phase 1 trial results for CTIM-76
-
Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
-
Eminent Announces Mobilization for Drilling at Hot Springs Range Project, Nevada
-
OpenText to invest €105 million in Ireland, creating 400 jobs
-
Edge Total Intelligence to Expand its U.S. Navy Presence: with U$1.2 Million Austal USA Contracts
-
Mineralys presents heart failure biomarker data for lorundrostat at ENDO 2026
-
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
-
X18ex Spotlights Roadmap and Enterprise-Grade Security Standards to Build Trust and Secure Market Share in DeFi.
-
SZ Pharma Delivers 600 sqm FDA-Certified Cleanroom Facility in Colombia
-
OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
-
PreveCeutical closes second tranche of private placement for $245,000
-
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
-
BlackRock Announces Product Updates
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
-
FDA approves Merck's KEYTRUDA and WELIREG combination for kidney cancer
-
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Ce
-
Precipio seeks shareholder votes to meet quorum for annual meeting
-
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
-
nuEra's Annual Juneteenth Fundraiser - Real Money for Real Change
-
Inspire Investing Screens SpaceX Negative, Citing Ownership of X Platform Documented for Child Sexual Exploitation
-
TGE's New Film "Dog Day Evening" Set to Be Released in Cinemas in June 2026
-
TGE Completes Interior Fit-Out of the World's Second L'OFFICIEL COFFEE in Macau
-
Protext Mobility Inc. (OTCID: TXTM) Unveils New Corporate Website and Investor Relations Platform to Support Strategic Growth and Exchange Uplisting
-
Ladybug Resource Group, Inc. Launches AI-Driven "Smart Supply Chain Hub," Redefining Global Sourcing for Non-Standard Industrial Components
-
TGE's Global Hospitality Portfolio exceeds US$860 million
-
Ladybug Resource Group, Inc. Launches AI-Driven "Smart Supply Chain Hub," Redefining Global Sourcing for Non-Standard Industrial Components
-
Ladybug Resource Group, Inc. Launches AI-Driven "Smart Supply Chain Hub," Redefining Global Sourcing for Non-Standard Industrial Components
